| Brandon Shutty, DO | |
|
510 S Cowley St, Spokane, WA 99202-1332 | |
| (509) 252-1299 | |
| Not Available |
| Full Name | Brandon Shutty |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 510 S Cowley St, Spokane, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598020059 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | OS13979 (Florida) | Primary |
| 207N00000X | Dermatology | OP61408379 (Washington) | Secondary |
| Entity Name | Premier Dermatology, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700202298 PECOS PAC ID: 6002031531 Enrollment ID: O20140625001928 |
News Archive
Ever wondered what happens inside your brain when you stay awake for a day, a night and another day, before you finally go to sleep? In a new study published today in the journal Science, a team of researchers from the University of Liege and the University of Surrey have scanned the brains of 33 participants across such a 2-day sleep deprivation period and following recovery sleep.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the presentation of data from its proof of concept study with lead CNS compound Serdaxin® at the 49th American College of Neuropsychopharmacologists (ACNP) Annual Meeting, held in Miami Beach, FL, December 5-9, 2010 at the Fountainbleau Resort.
A group of scientists from the Research Center of Neurology and Skoltech showed that human working memory can be tweaked using non-invasive magnetic stimulation of the brain. Also, they discovered that the effect of magnetic stimulation weakens as the brain works on a cognitive task under stimulation.
Cempra Pharmaceuticals today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of oral administration of our fourth generation macrolide, solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with oral levofloxacin for the treatment of community-acquired bacterial pneumonia (CABP).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brandon Shutty, DO 4197 Woodlands Pkwy, Palm Harbor, FL 34685-3493 Ph: (727) 786-3810 | Brandon Shutty, DO 510 S Cowley St, Spokane, WA 99202-1332 Ph: (509) 252-1299 |
News Archive
Ever wondered what happens inside your brain when you stay awake for a day, a night and another day, before you finally go to sleep? In a new study published today in the journal Science, a team of researchers from the University of Liege and the University of Surrey have scanned the brains of 33 participants across such a 2-day sleep deprivation period and following recovery sleep.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the presentation of data from its proof of concept study with lead CNS compound Serdaxin® at the 49th American College of Neuropsychopharmacologists (ACNP) Annual Meeting, held in Miami Beach, FL, December 5-9, 2010 at the Fountainbleau Resort.
A group of scientists from the Research Center of Neurology and Skoltech showed that human working memory can be tweaked using non-invasive magnetic stimulation of the brain. Also, they discovered that the effect of magnetic stimulation weakens as the brain works on a cognitive task under stimulation.
Cempra Pharmaceuticals today announced results from its Phase II clinical trial investigating the efficacy, safety and tolerability of oral administration of our fourth generation macrolide, solithromycin (CEM-101), a fluoroketolide antibiotic, in comparison with oral levofloxacin for the treatment of community-acquired bacterial pneumonia (CABP).
› Verified 2 days ago
William Philip Werschler, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 104 W 5th Ave, 330w, Spokane, WA 99204 Phone: 509-624-1184 Fax: 509-625-1449 | |
Daniel Bowen Baird, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 757 E Holland Ave, Spokane, WA 99218 Phone: 509-444-6367 Fax: 509-444-6371 | |
Dr. Michael E Ryan, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 5901 N Lidgerwood St, Ste 118, Spokane, WA 99208 Phone: 509-483-2828 Fax: 509-484-7882 | |
James Keith Parker, MD Dermatology Medicare: Medicare Enrolled Practice Location: 5905 N Mayfair St Ste 200, Spokane, WA 99208 Phone: 509-456-7414 Fax: 800-247-9519 | |
Myron Zhang, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 400 E 5th Ave Ste 4, Spokane, WA 99202 Phone: 509-342-3945 Fax: 509-755-6580 | |
Benjamin Hsu, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 757 E Holland Ave, Northwest Dermatology, Spokane, WA 99218 Phone: 509-444-6367 Fax: 509-444-6371 | |
Dr. Lark Greenwald Guss, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 510 S Cowley St Ste 200, Spokane, WA 99202 Phone: 509-456-8444 Fax: 509-455-9227 |